(lp0
S"Why Portola Pharmaceuticals Inc Stock Surged Higher Today Motley Fool - Dec 23, 2016 Shares of clinical stage anticoagulant specialist Portola Pharmaceuticals Inc  rose 33.5% at the end of Friday's session.Portola Shares Surge on Application Acceptance - Wall Street Journal"
p1
aS'Why Portola Pharmaceuticals Inc Is Plunging Today Motley Fool - Aug 18, 2016 What: Shares of Portola Pharmaceuticals , a clinical-stage biotech focused primarily on hematologic diseases, are down by more than 18% as of 10:40 a.m.Portola Pharmaceuticals Inc : A Misinterpretation Discount? - Market ExclusivePortola Pharmaceuticals Receives Complete Response Letter from FDA for ... - GlobeNewswire '
p2
aS'FDA Informs Portola Pharmaceuticals at Mid-Cycle Review for Betrixaban That It ... GlobeNewswire  - Feb 8, 2017 SOUTH SAN FRANCISCO, Calif., Feb. 08, 2017  -- Portola Pharmaceuticals, Inc.  today announced that the U.S.'
p3
aS'BRIEF-Portola Pharmaceuticals Inc signed a $150 million royalty agreement with ... Reuters - Feb 3, 2017 Feb 12 United Airlines replaced a pilot before takeoff on Saturday after she boarded in civilian clothes and told passengers over the intercom that both Donald Trump and Hillary Clinton were liars and that she was getting a divorce, witnesses said.'
p4
aS"Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial ... GlobeNewswire  - Feb 28, 2017 Collaboration and license revenue earned under Portola's collaboration and license agreements with Bristol-Myers Squibb Company and Pfizer, Bayer Pharma and Janssen Pharmaceuticals, Daiichi Sankyo and Dermavant Sciences was $13.7 million for the&nbsp;...Portola Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 01 - Equities.com"
p5
aS"Portola Pharmaceuticals Announces Betrixaban and AndexXa (andexanet alfa ... GlobeNewswire  - Mar 7, 2017 SOUTH SAN FRANCISCO, Calif., March 07, 2017  -- Portola Pharmaceuticals Inc.  today announced that new data from the pivotal Phase 3 APEX Study of the Company's investigational drug betrixaban will be&nbsp;...Rating Change on Portola Pharmaceuticals, Inc.  - Energy Index"
p6
aS"Portola Pharmaceuticals to Announce Fourth Quarter and Year-End 2016 Financial ... Yahoo Finance - Feb 21, 2017 21, 2017  -- Portola Pharmaceuticals, Inc.  announced today that it will host a webcast and conference call to discuss the Company's financial results for the quarter and year ended December 31, 2016, and provide a general&nbsp;...Portola Pharmaceuticals Inc.  Breaks into New 52-Week High on February ... - Equities.com"
p7
aS"Today's Brokerage Rating: HealthSouth Corporation , Portola ... StockNewsJournal - Mar 16, 2017 Portola Pharmaceuticals, Inc. , maintained return on investment for the last twelve months at -74.02, higher than what Reuters data shows regarding industry's average.The Portola Pharmaceuticals Inc  Shares Sold by Fmr LLC - Petro Global News 24"
p8
aS"Revenue Approximations Analysis: Ralph Lauren Corporation , Portola ... StockNewsJournal - Mar 14, 2017 Portola Pharmaceuticals, Inc. , maintained return on investment for the last twelve months at -74.02, higher than what Reuters data shows regarding industry's average."
p9
aS'Portola Pharmaceuticals Reaches Analyst Target Price Nasdaq - Feb 22, 2017 In recent trading, shares of Portola Pharmaceuticals, Inc.  have crossed above the average analyst 12-month target price of $32.33, changing hands for $32.66/share.'
p10
a.